Are open to ongoing care, including follow-ups and dose adjustments when needed
Protection against nerve cell damage
Other differential diagnoses of pigmented lesion of the mouth consist of smokers melanosis, Addisons disease, blue nevi, Albright syndrome, foreign bodies, Peutz-Jeghers syndrome, drug-induced pigmentation, and Laugier-Hunziker syndrome (4)
Dosing fundamentals Administration: Once weekly subcutaneous injection Same day each week (consistency matters) Preferably at the same time of day Half-life: Approximately 6 days, supporting weekly dosing Dose escalation: Every 4 weeks, unless: Side effects require holding current dose Individual tolerance suggests faster/slower progression Healthcare provider recommends adjustment Clinical trial doses tested The Phase 2 obesity trial tested multiple dosing arms: Key insight: 8 mg produces nearly the same results as 12 mg with fewer side effectsmaking it a potential "sweet spot" for many users
How can I tell if the rubber stopper on the vial is still sterile